This document is an excerpt from the EUR-Lex website
Document 22026D0669
Decision of the EEA Joint Committee No 272/2025 of 5 December 2025 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2026/669]
Decision of the EEA Joint Committee No 272/2025 of 5 December 2025 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2026/669]
Decision of the EEA Joint Committee No 272/2025 of 5 December 2025 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2026/669]
OJ L, 2026/669, 16.4.2026, ELI: http://data.europa.eu/eli/dec/2026/669/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
In force
|
Official Journal |
EN L series |
|
2026/669 |
16.4.2026 |
DECISION OF THE EEA JOINT COMMITTEE No 272/2025
of 5 December 2025
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2026/669]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,
Whereas:
|
(1) |
Commission Delegated Regulation (EU) 2024/1159 of 7 February 2024 supplementing Regulation (EU) 2019/6 of the European Parliament and of the Council by laying down rules on appropriate measures to ensure the effective and safe use of veterinary medicinal products authorised and prescribed for oral administration via routes other than medicated feed and administered by the animal keeper to food-producing animals (1) is to be incorporated into the EEA Agreement. |
|
(2) |
This Decision concerns legislation regarding veterinary matters. Legislation regarding veterinary matters shall not apply to Liechtenstein as long as the application of the Agreement between the European Community and the Swiss Confederation on trade in agricultural products is extended to Liechtenstein. Delegated Regulation (EU) 2024/1159 shall therefore not apply to Liechtenstein. |
|
(3) |
Annex II to the EEA Agreement should therefore be amended accordingly, |
HAS ADOPTED THIS DECISION:
Article 1
The following is inserted after point 22o (Commission Implementing Regulation (EU) 2024/1973) of Chapter XIII of Annex II to the EEA Agreement:
|
‘22p. |
32024 R 1159: Commission Delegated Regulation (EU) 2024/1159 of 7 February 2024 supplementing Regulation (EU) 2019/6 of the European Parliament and of the Council by laying down rules on appropriate measures to ensure the effective and safe use of veterinary medicinal products authorised and prescribed for oral administration via routes other than medicated feed and administered by the animal keeper to food-producing animals (OJ L, 2024/1159, 19.4.2024). The provisions of the Regulation shall, for the purposes of this Agreement, be read with the following adaptation: This Regulation shall not apply to Liechtenstein.’ |
Article 2
The text of Delegated Regulation (EU) 2024/1159 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 6 December 2025, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 5 December 2025.
For the EEA Joint Committee
The President
Stefán Haukur JÓHANNESSON
(1) OJ L, 2024/1159, 19.4.2024, ELI: http://data.europa.eu/eli/reg_del/2024/1159/oj.
(*1) No constitutional requirements indicated.
ELI: http://data.europa.eu/eli/dec/2026/669/oj
ISSN 1977-0677 (electronic edition)